Aprogen Healthcare & Games Inc
Aprogen Healthcare & Games Inc. engages in the development of medicines using biomedical technology. The company operates through Game Business, Rental Profit, and Pharmaceutical divisions. It offers specialty drugs, such as antibiotics, circulatory system, digestive system, anti-inflammatory, and analgesic drugs. The company also offers wireless remote lighting monitoring and control system for … Read more
Aprogen Healthcare & Games Inc - Asset Resilience Ratio
Aprogen Healthcare & Games Inc (109960) has an Asset Resilience Ratio of 6.55% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2024)
This chart shows how Aprogen Healthcare & Games Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Aprogen Healthcare & Games Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩21.28 Billion | 6.55% |
| Total Liquid Assets | ₩21.28 Billion | 6.55% |
Asset Resilience Insights
- Limited Liquidity: Aprogen Healthcare & Games Inc maintains only 6.55% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Aprogen Healthcare & Games Inc Industry Peers by Asset Resilience Ratio
Compare Aprogen Healthcare & Games Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
AGP Ltd
KAR:AGP |
Pharmaceuticals | 0.71% |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250 |
Pharmaceuticals | 4.82% |
|
DongKoo Bio&Pharma Co. Ltd
KQ:006620 |
Pharmaceuticals | 4.28% |
|
NatureCell Co.Ltd
KQ:007390 |
Pharmaceuticals | 0.00% |
|
Sam-A Pharm. Co. Ltd
KQ:009300 |
Pharmaceuticals | 34.37% |
|
Kyung Dong Pharmaceutical Co. Ltd
KQ:011040 |
Pharmaceuticals | 5.22% |
|
WooGene B&G Co. Ltd
KQ:018620 |
Pharmaceuticals | 3.35% |
|
Oscotec Inc
KQ:039200 |
Pharmaceuticals | 61.00% |
Annual Asset Resilience Ratio for Aprogen Healthcare & Games Inc (2013–2024)
The table below shows the annual Asset Resilience Ratio data for Aprogen Healthcare & Games Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 11.34% | ₩37.97 Billion | ₩334.89 Billion | +11.02pp |
| 2023-12-31 | 0.32% | ₩1.00 Billion | ₩316.56 Billion | -42.46pp |
| 2022-12-31 | 42.77% | ₩91.27 Billion | ₩213.39 Billion | +17.90pp |
| 2021-12-31 | 24.87% | ₩56.39 Billion | ₩226.74 Billion | +11.49pp |
| 2020-12-31 | 13.38% | ₩31.70 Billion | ₩236.89 Billion | -7.68pp |
| 2019-12-31 | 21.06% | ₩46.00 Billion | ₩218.36 Billion | +15.38pp |
| 2018-12-31 | 5.68% | ₩13.52 Billion | ₩237.93 Billion | -45.09pp |
| 2017-12-31 | 50.78% | ₩71.97 Billion | ₩141.75 Billion | +13.61pp |
| 2016-12-31 | 37.16% | ₩5.80 Billion | ₩15.61 Billion | +35.60pp |
| 2015-12-31 | 1.56% | ₩424.20 Million | ₩27.11 Billion | -5.44pp |
| 2013-12-31 | 7.00% | ₩847.85 Million | ₩12.11 Billion | -- |